Literature DB >> 6788246

Hyperglycaemic effect of nifedipine.

S Charles, J M Ketelslegers, M Buysschaert, A E Lambert.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1981        PMID： 6788246      PMCID： PMC1506021          DOI： 10.1136/bmj.283.6283.19

Source DB:  PubMed          Journal:  Br Med J (Clin Res Ed)        ISSN： 0267-0623


× No keyword cloud information.
  2 in total

1.  Drugs and the heart. III. Calcium antagonists.

Authors:  L H Opie
Journal:  Lancet       Date:  1980-04-12       Impact factor: 79.321

2.  Impairment of insulin secretion in man by nifedipine.

Authors:  D Giugliano; R Torella; F Cacciapuoti; S Gentile; M Verza; M Varricchio
Journal:  Eur J Clin Pharmacol       Date:  1980-11       Impact factor: 2.953
  2 in total
  34 in total

Review 1.  Effects of drugs on glucose tolerance in non-insulin-dependent diabetics (Part II).

Authors:  S O'Byrne; J Feely
Journal:  Drugs       Date:  1990-08       Impact factor: 9.546

Review 2.  Nifedipine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy, in ischaemic heart disease, hypertension and related cardiovascular disorders.

Authors:  E M Sorkin; S P Clissold; R N Brogden
Journal:  Drugs       Date:  1985-09       Impact factor: 9.546

Review 3.  Calcium antagonists--adverse drug interactions.

Authors:  H Reicher-Reiss; H N Neufeld; F X Ebner
Journal:  Cardiovasc Drugs Ther       Date:  1987-12       Impact factor: 3.727

Review 4.  Recent Advances in Pharmacological Management of Hypertension in Diabetic Patients with Nephropathy : Effects of Antihypertensive Drugs on Kidney Function and Insulin Sensitivity.

Authors:  Tsuneharu Baba; Takashi Ishizaki
Journal:  Drugs       Date:  1992-04       Impact factor: 9.546

5.  Evolution of insulin resistance in coronary artery disease patients on four different pharmacological therapies.

Authors:  G Piédrola; E Novo; J Serrano-Gotarredona; M L de Teresa; R García-Robles
Journal:  Postgrad Med J       Date:  1999-01       Impact factor: 2.401

6.  The effect of nicardipine on glucose and drug-stimulated insulin secretion in normal volunteers.

Authors:  R J Dow; J Baty; T E Isles
Journal:  Br J Clin Pharmacol       Date:  1985       Impact factor: 4.335

7.  Metabolic parameters after changing from hydrochlorothiazide to verapamil treatment in hypertension.

Authors:  A Lehtonen; A Gordin
Journal:  Eur J Clin Pharmacol       Date:  1984       Impact factor: 2.953

8.  Calcium antagonists and endocrine status: lack of effect of oral verapamil on pituitary-testicular and pituitary-thyroid function.

Authors:  C G Semple; J A Thomson; G H Beastall; A R Lorimer
Journal:  Br J Clin Pharmacol       Date:  1984-02       Impact factor: 4.335

9.  Insulin secretion and glucose tolerance in non-insulin dependent diabetic patients after chronic nifedipine treatment.

Authors:  A Tentorio; G Ghilardi; A Pedroncelli; R Benco; S Stroppa; S Adib; D Gianola; G Pagani
Journal:  Eur J Clin Pharmacol       Date:  1989       Impact factor: 2.953

10.  Glucose tolerance in hypertensive patients during treatment with the calcium antagonist, felodipine.

Authors:  T Hedner; D Elmfeldt; H Von Schenck; E Sjögren; U Smith
Journal:  Br J Clin Pharmacol       Date:  1987-08       Impact factor: 4.335
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.